Lee, G.Y.; Mubasher, M.; McKenzie, T.S.; Schmitt, N.C.; Sebelik, M.E.; Flanagan, C.E.; Osta, B.E.; Cothran, M.B.; Green, H.-N.
Assessment of a Nano-Docetaxel Combined Treatment for Head and Neck Cancer. Onco 2021, 1, 83-94.
https://doi.org/10.3390/onco1020007
AMA Style
Lee GY, Mubasher M, McKenzie TS, Schmitt NC, Sebelik ME, Flanagan CE, Osta BE, Cothran MB, Green H-N.
Assessment of a Nano-Docetaxel Combined Treatment for Head and Neck Cancer. Onco. 2021; 1(2):83-94.
https://doi.org/10.3390/onco1020007
Chicago/Turabian Style
Lee, Gee Young, Mohamed Mubasher, Tamra S. McKenzie, Nicole C. Schmitt, Merry E. Sebelik, Carrie E. Flanagan, Badi El Osta, Maya B. Cothran, and Hadiyah-Nicole Green.
2021. "Assessment of a Nano-Docetaxel Combined Treatment for Head and Neck Cancer" Onco 1, no. 2: 83-94.
https://doi.org/10.3390/onco1020007
APA Style
Lee, G. Y., Mubasher, M., McKenzie, T. S., Schmitt, N. C., Sebelik, M. E., Flanagan, C. E., Osta, B. E., Cothran, M. B., & Green, H.-N.
(2021). Assessment of a Nano-Docetaxel Combined Treatment for Head and Neck Cancer. Onco, 1(2), 83-94.
https://doi.org/10.3390/onco1020007